In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ as well as invasive breast cancer.
Scientists show direct link between reduced hormone therapy and declines in invasive breast cancer